About company

IGNITE Immunotherapy is working to unlock the full potential of cancer immunotherapy. Their optimized intravenous oncolytic cancer vaccines are designed to complement approved immune checkpoint inhibitors by igniting an immune response to patients’ cancers. Their purpose is to cure cancer patients through combination immunotherapy with their intravenous oncolytic vaccines.

US
Unknown
Not verified company